Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
169.92
+0.15 (0.09%)
Sep 30, 2025, 3:00 PM CST
0.09%
Market Cap15.09B
Revenue (ttm)466.00M
Net Income (ttm)-231.53M
Shares Out88.83M
EPS (ttm)-2.54
PE Ration/a
Forward PEn/a
Dividend0.20 (0.12%)
Ex-Dividend Daten/a
Volume1,391,551
Average Volume3,134,499
Open169.31
Previous Close169.77
Day's Range167.18 - 171.70
52-Week Range26.65 - 262.22
Beta1.73
RSI38.84
Earnings DateOct 31, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 903
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.